Search images on Google      Product Monograph

Active Ingredients:

• eribulin mesylate, 0.5 MG/ML

DIN: 02539136

Dosage Form(s): SOLUTION

Route(s) of Administration: INTRAVENOUS

Description: SINGLE USE

Schedule: Prescription

Company: NATCO PHARMA (CANADA) INC

ATC:

• L01 - ANTINEOPLASTIC AGENTS (ATC, WHO, Wiki)
• L01X - OTHER ANTINEOPLASTIC AGENTS (ATC, WHO)
• L01XX - Other antineoplastic agents (ATC, WHO)
• L01XX41 - ERIBULIN (WHO)

Reference brand drug: Halaven

 

External Links for Nat-Eribulin:

Search on Google

• Nat-Eribulin side effects
• Nat-Eribulin dosage
• eribulin mesylate side effects
• eribulin mesylate dosage